Tuesday, January 23, 2018

Obalon Therapeutics (OBLN) Terminates Offering of Common Stock After Whistleblower Contacts ...

However, a purported whistleblower contacted KPMG LLP, the Company's independent auditors, to make certain allegations relating to allegedly improper revenue recognition during the Company's fourth fiscal quarter of 2017 (“Q4 2017”). These allegations were reported to Obalon late in the day on ...
Delivered by KPMG Today (@KPMG_TO)
Article continues here
Follow @KPMG_TO on Twitter to get latest updates